Fludrocortisone Acetate USP For Compounding (API)

Fludrocortisone acetate USP is a synthetic corticosteroid derived from hydrocortisone. It is used as an active pharmaceutical ingredient in the compounding of medications for conditions that require mineralocorticoid activity, such as primary or secondary adrenocortical insufficiency, salt-losing adrenogenital syndrome, and orthostatic hypotension. It works by increasing the reabsorption of sodium and water and excretion of potassium in the kidneys, maintaining electrolyte balance in the body.

Fludrocortisone acetate USP is a synthetic corticosteroid hormone used to treat conditions such as low levels of aldosterone hormone, inflammation, and low blood pressure. It is primarily used in compounding to prepare customized formulations for patients who are unable to take commercially available forms of the medication. Compounded medications allow for personalized dosing and can be prepared in different delivery forms, such as oral suspensions or transdermal gels. Fludrocortisone acetate USP is also used in compounding to treat adrenal insufficiency and certain skin conditions, such as eczema and psoriasis.